Findings

What do systematic reviews say?

630 questions · 634 findings · 285 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 316 · 49.8%GRADE not reported 40 · 6.3%Very low 95 · 15%Low 111 · 17.5%Moderate 60 · 9.5%High 12 · 1.9%

External beam radiotherapy (EBRT) plus transarterial chemoembolisation (TACE) vs TACE alone

Health‐related quality of life · participants with unresectable hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

External beam radiotherapy for unresectable hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hyperbaric oxygen therapy plus standard care (surgery, antibiotics, oral rinse) vs Standard care alone (surgery, antibiotics, oral rinse)

Quality of life · People with BRONJ (mean age ~66 years; most treated with bisphosphonates for cancer (multiple myeloma, breast cancer) or osteoporosis)

1 finding from 1 review

Interventions for treating bisphosphonate‐related osteonecrosis of the jaw (BRONJ) 2016 · Cochrane All outcomes
Baseline and 6 months
no estimate extracted
1 study · 49 participants
GRADE not reported

Immunomodulatory drug maintenance therapy vs placebo/observation

Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Exercise therapy plus antidepressants vs antidepressants alone

QoL · men and women aged over 18 years with chronic fatigue syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs sulphonylureas

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs thiazolidinediones

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs dipeptidyl‐peptidase 4 inhibitors

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs glucagon like peptide‐1 analogues

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs meglitinides

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Stem cell therapy vs any other modality of treatment

Pain Measured using a validated pain score or scale, or quality of life questionnaire · patients with Buerger's disease

The review found no eligible studies for this question.

1 finding from 1 review

Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease) 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Health‐related quality of life measured using QUALID (12–45, higher score indicates poorer quality of life) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 164 participants
Moderate

Home‐based exercise therapy vs walking advice

Health‐related quality of life (mental) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Supervised exercise therapy vs walking advice

Health‐related quality of life (mental) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 296 participants
Low

Home‐based exercise therapy vs walking advice

Quality of Life: SF‐36 (physical component) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Supervised exercise therapy vs walking advice

Quality of Life: SF‐36 (physical component) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 296 participants
Low

Pressure‐garment therapy (PGT) vs silicone

QoL · people with burn wounds likely to develop hypertrophic scarring

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 159 participants
Very low

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Quality of life: no significant change in quality of life/satisfaction medium term (3‐12 months) not reported · schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Group C cognitive behavioural therapy: cognitive behavioural therapy + placebo vs placebo or supportive treatment

Quality of life QLS · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Very low

Group B cognitive behavioural therapy: cognitive behavioural therapy + risperidone vs placebo and cognitive and behavioural therapies

QoL · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 51 participants
Very low

Group C cognitive behavioural therapy: cognitive behavioural therapy + risperidone vs placebo or supportive treatment

Quality of life QLS · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low